These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33077915)

  • 1. Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option.
    Ng KW; Attig J; Bolland W; Young GR; Major J; Wrobel AG; Gamblin S; Wack A; Kassiotis G
    Nat Genet; 2020 Dec; 52(12):1294-1302. PubMed ID: 33077915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor.
    Onabajo OO; Banday AR; Stanifer ML; Yan W; Obajemu A; Santer DM; Florez-Vargas O; Piontkivska H; Vargas JM; Ring TJ; Kee C; Doldan P; Tyrrell DL; Mendoza JL; Boulant S; Prokunina-Olsson L
    Nat Genet; 2020 Dec; 52(12):1283-1293. PubMed ID: 33077916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection.
    Blume C; Jackson CL; Spalluto CM; Legebeke J; Nazlamova L; Conforti F; Perotin JM; Frank M; Butler J; Crispin M; Coles J; Thompson J; Ridley RA; Dean LSN; Loxham M; Reikine S; Azim A; Tariq K; Johnston DA; Skipp PJ; Djukanovic R; Baralle D; McCormick CJ; Davies DE; Lucas JS; Wheway G; Mennella V
    Nat Genet; 2021 Feb; 53(2):205-214. PubMed ID: 33432184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ILRUN Downregulates ACE2 Expression and Blocks Infection of Human Cells by SARS-CoV-2.
    Tribolet L; Alexander MR; Brice AM; van Vuren PJ; Rootes CL; Mara K; McDonald M; Bruce KL; Gough TJ; Shi S; Cowled C; Bean AGD; Stewart CR
    J Virol; 2021 Jul; 95(15):e0032721. PubMed ID: 33963054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction.
    Biagioli M; Marchianò S; Roselli R; Di Giorgio C; Bellini R; Bordoni M; Gidari A; Sabbatini S; Francisci D; Fiorillo B; Catalanotti B; Distrutti E; Carino A; Zampella A; Costantino G; Fiorucci S
    Biochem Pharmacol; 2021 Jun; 188():114564. PubMed ID: 33872570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway.
    Chen J; Liu J; Chen Z; Peng H; Zhu C; Feng D; Zhang S; Zhao P; Zhang X; Xu J
    mSphere; 2022 Aug; 7(4):e0021122. PubMed ID: 35862802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation.
    Tang Q; Wang Y; Ou L; Li J; Zheng K; Zhan H; Gu J; Zhou G; Xie S; Zhang J; Huang W; Wang S; Wang X
    Int J Biol Sci; 2021; 17(8):1925-1939. PubMed ID: 34131396
    [No Abstract]   [Full Text] [Related]  

  • 9. Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection.
    Zhuang MW; Cheng Y; Zhang J; Jiang XM; Wang L; Deng J; Wang PH
    J Med Virol; 2020 Nov; 92(11):2693-2701. PubMed ID: 32497323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?
    Scagnolari C; Bitossi C; Viscido A; Frasca F; Oliveto G; Scordio M; Petrarca L; Mancino E; Nenna R; Riva E; De Vito C; Midulla F; Antonelli G; Pierangeli A
    Cytokine; 2021 Apr; 140():155430. PubMed ID: 33508651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE2 Affects the Expression and Function of IFITM3 During SARS-CoV-2 Pseudovirus Infection in Vero E6 Cells.
    Long S; Li S; Zhang X; Peng Q; Chen S; Wang J
    Viral Immunol; 2022 Dec; 35(10):653-662. PubMed ID: 36178477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection.
    Chaouat AE; Achdout H; Kol I; Berhani O; Roi G; Vitner EB; Melamed S; Politi B; Zahavy E; Brizic I; Lenac Rovis T; Alfi O; Wolf D; Jonjic S; Israely T; Mandelboim O
    PLoS Pathog; 2021 Dec; 17(12):e1010175. PubMed ID: 34929007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.
    Pierce JB; Simion V; Icli B; Pérez-Cremades D; Cheng HS; Feinberg MW
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33207533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
    Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
    J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling.
    Karthika T; Joseph J; Das VRA; Nair N; Charulekha P; Roji MD; Raj VS
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions.
    Rawle DJ; Le TT; Dumenil T; Yan K; Tang B; Nguyen W; Watterson D; Modhiran N; Hobson-Peters J; Bishop C; Suhrbier A
    PLoS Pathog; 2021 Jul; 17(7):e1009723. PubMed ID: 34214142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection
    Curreli F; Victor SMB; Ahmed S; Drelich A; Tong X; Tseng CK; Hillyer CD; Debnath AK
    mBio; 2020 Dec; 11(6):. PubMed ID: 33310780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2.
    El-Shennawy L; Hoffmann AD; Dashzeveg NK; McAndrews KM; Mehl PJ; Cornish D; Yu Z; Tokars VL; Nicolaescu V; Tomatsidou A; Mao C; Felicelli CJ; Tsai CF; Ostiguin C; Jia Y; Li L; Furlong K; Wysocki J; Luo X; Ruivo CF; Batlle D; Hope TJ; Shen Y; Chae YK; Zhang H; LeBleu VS; Shi T; Swaminathan S; Luo Y; Missiakas D; Randall GC; Demonbreun AR; Ison MG; Kalluri R; Fang D; Liu H
    Nat Commun; 2022 Jan; 13(1):405. PubMed ID: 35058437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
    Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues.
    Li MY; Li L; Zhang Y; Wang XS
    Infect Dis Poverty; 2020 Apr; 9(1):45. PubMed ID: 32345362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.